PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
ProPhase Labs, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026
- Market cap
- $119.68K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | – | – | – | – |
| FY2023 | – | – | $0 | 0.0% |
| FY2022 | – | – | $9.35M | 50.7% |
| FY2021 | $3.10 | – | $4.55M | 72.5% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.